AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
Michael R Graham1, Peter Evans2, Bruce Davies1, Julien S Baker11Health and Exercise Science Research Unit, Faculty of Health Sport and Science, University of Glamorgan, Pontypridd, Wales, United Kingdom; 2Royal Gwent Hospital, Newport, Gwent, United KingdomAbstract: The nontherapeutic use of prescri...
Enregistré dans:
Auteurs principaux: | Michael R Graham, Peter Evans, Bruce Davies, Julien S Baker |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/614d6ca296d44551a5d3ae5d5b891dda |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Synthetic cathinone abuse
par: Capriola M
Publié: (2013) -
Detemir as a once-daily basal insulin in type 2 diabetes
par: Nelson SE
Publié: (2011) -
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
par: Davies M, et autres
Publié: (2016) -
Choline Chloride Mediates Salinity Tolerance in Cluster Bean ( L.) by Improving Growth, Oxidative Defense, and Secondary Metabolism
par: Saima Riaz PhD, et autres
Publié: (2021) -
Impact of the chronic disease self-management program (CDSMP) on self-perceived frailty condition: the EU-EFFICHRONIC project
par: Sabrina Zora, et autres
Publié: (2021)